Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    Stenoparib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Allarity Therapeutics Unveils Stenoparib/2x-121 Phase 2 Data:
    Allarity Therapeutics Unveils Stenoparib/2x-121 Phase 2 Data:

    22 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/22/3153846/0/en/Allarity-Therapeutics-Presents-New-Phase-2-Clinical-Data-for-Stenoparib-2X-121-Showing-Landmark-Median-Overall-Survival-Has-Now-Surpassed-25-Months.html

    GLOBENEWSWIRE
    22 Sep 2025
    Share Share
    Allarity CEO to Present at Biomarkers & Precision Medicine 2025
    Allarity CEO to Present at Biomarkers & Precision Medicine 2025

    17 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/17/3151554/0/en/Allarity-Therapeutics-CEO-to-Present-at-Biomarkers-Precision-Medicine-2025.html

    GLOBENEWSWIRE
    17 Sep 2025
    Share Share
    Allarity Gets FDA Fast Track for Stenoparib in Ovarian Cancer
    Allarity Gets FDA Fast Track for Stenoparib in Ovarian Cancer

    26 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/26/3139198/0/en/Allarity-Therapeutics-Granted-FDA-Fast-Track-Designation-for-Stenoparib-for-the-Treatment-of-Advanced-Ovarian-Cancer.html

    GLOBENEWSWIRE
    26 Aug 2025
    Share Share
    Allarity Therapeutics Doses Second Patient in Stenoparib Phase 2
    Allarity Therapeutics Doses Second Patient in Stenoparib Phase 2

    27 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/27/3106506/0/en/Allarity-Therapeutics-Announces-Dosing-of-Second-Patient-in-New-Phase-2-Trial-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

    GLOBENEWSWIRE
    27 Jun 2025
    Share Share
    Allarity Dose 1st Patient in Ph2 Stenoparib Ovarian Cancer Trial
    Allarity Dose 1st Patient in Ph2 Stenoparib Ovarian Cancer Trial

    05 Jun 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/diagnostic-center/allarity-announces-enrolment-of-first-patient-in-phase-2-clinical-trial-protocol-of-stenoparib-in-advanced-ovarian-cancer-17245

    INDPHARMAPOST
    05 Jun 2025
    Share Share
    Allarity Therapeutics Enrolls First Patient in Stenoparib Phase 2
    Allarity Therapeutics Enrolls First Patient in Stenoparib Phase 2

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3091778/0/en/Allarity-Therapeutics-Announces-First-Patient-Enrolled-in-New-Phase-2-Clinical-Trial-Protocol-of-Stenoparib-in-Advanced-Ovarian-Cancer.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share